Warning! GuruFocus detected
1 Severe warning sign
with ERFO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Laboratorio Farmaceutico Erfo SpA
ISIN : IT0005497885
Compare
Compare
Traded in other countries / regions
ERFO.ItalyRK7.Germany IPO Date
2022-06-29Description
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.83 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.3 | |||||
| Interest Coverage | 22.55 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.72 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | -2.8 | |||||
| 3-Year EPS without NRI Growth Rate | -17.6 | |||||
| 3-Year Book Growth Rate | -12.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.44 | |||||
| 9-Day RSI | 30.71 | |||||
| 14-Day RSI | 33.38 | |||||
| 3-1 Month Momentum % | -6.69 | |||||
| 6-1 Month Momentum % | 29.27 | |||||
| 12-1 Month Momentum % | 10.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 1.16 | |||||
| Cash Ratio | 0.62 | |||||
| Days Inventory | 111.13 | |||||
| Days Sales Outstanding | 37.71 | |||||
| Days Payable | 68.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.66 | |||||
| Dividend Payout Ratio | 1.21 | |||||
| Forward Dividend Yield % | 5.66 | |||||
| 5-Year Yield-on-Cost % | 5.93 | |||||
| 3-Year Average Share Buyback Ratio | 1.5 | |||||
| Shareholder Yield % | 12.18 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.54 | |||||
| Operating Margin % | 11.45 | |||||
| Net Margin % | 7.09 | |||||
| FCF Margin % | 16.84 | |||||
| ROE % | 6.26 | |||||
| ROA % | 3.88 | |||||
| ROIC % | 5.56 | |||||
| 3-Year ROIIC % | -17.19 | |||||
| ROC (Joel Greenblatt) % | 23.26 | |||||
| ROCE % | 6.9 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.11 | |||||
| PE Ratio without NRI | 22.26 | |||||
| Price-to-Owner-Earnings | 12.97 | |||||
| PS Ratio | 1.77 | |||||
| PB Ratio | 1.34 | |||||
| Price-to-Tangible-Book | 2.29 | |||||
| Price-to-Free-Cash-Flow | 10.44 | |||||
| Price-to-Operating-Cash-Flow | 7.71 | |||||
| EV-to-EBIT | 13.74 | |||||
| EV-to-EBITDA | 6.33 | |||||
| EV-to-Revenue | 1.45 | |||||
| EV-to-FCF | 9.22 | |||||
| Price-to-Graham-Number | 1.45 | |||||
| Price-to-Net-Current-Asset-Value | 9.17 | |||||
| Earnings Yield (Greenblatt) % | 7.28 | |||||
| FCF Yield % | 10.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Laboratorio Farmaceutico Erfo SpA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.711 | ||
| EPS (TTM) (€) | 0.047 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 41.85 | ||
| 14-Day RSI | 33.38 | ||
| 14-Day ATR (€) | 0.054052 | ||
| 20-Day SMA (€) | 1.24775 | ||
| 12-1 Month Momentum % | 10.88 | ||
| 52-Week Range (€) | 0.88 - 1.7 | ||
| Shares Outstanding (Mil) | 8.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Laboratorio Farmaceutico Erfo SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Laboratorio Farmaceutico Erfo SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Laboratorio Farmaceutico Erfo SpA Frequently Asked Questions
What is Laboratorio Farmaceutico Erfo SpA(MIL:ERFO)'s stock price today?
The current price of MIL:ERFO is €1.10. The 52 week high of MIL:ERFO is €1.70 and 52 week low is €0.88.
When is next earnings date of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO)?
The next earnings date of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) is .
Does Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) pay dividends? If so, how much?
The Dividend Yield %  of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) is 5.66% (As of Today), Highest Dividend Payout Ratio of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) was 1.21. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) is 5.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers